How severe is CVE-2016-8355?

CVE-2016-8355 has a CVSS 3.x base score of 9.9, rated critical severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2016-8355 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (71st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2016-8355?

CVE-2016-8355 primarily affects Smiths-medical Cadd-solis Medication Safety Software. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2016-8355?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2016-8355 published?

CVE-2016-8355 was published on 2017-02-13 and last updated on 2026-06-17.

CVE-2016-8355

CVE-2016-8355 is a critical-severity vulnerability in Smiths-medical Cadd-solis Medication Safety Software with a CVSS 3.x base score of 9.9. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-306.

Key facts

Severity: Critical (CVSS 3.x base score 9.9)
CVSS v2: 9.0
EPSS exploit prediction: 1% (71st percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-306
Affected product: Smiths-medical Cadd-solis Medication Safety Software
Published: 2017-02-13
Last modified: 2026-06-17

Description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

Frequently asked questions

What is CVE-2016-8355?: An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
How severe is CVE-2016-8355?: CVE-2016-8355 has a CVSS 3.x base score of 9.9, rated critical severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2016-8355 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (71st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2016-8355?: CVE-2016-8355 primarily affects Smiths-medical Cadd-solis Medication Safety Software. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2016-8355?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2016-8355 published?: CVE-2016-8355 was published on 2017-02-13 and last updated on 2026-06-17.

References

Affected products (4)

cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:1.0:*:*:*:*:*:*:*
cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:2.0:*:*:*:*:*:*:*
cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:3.0:*:*:*:*:*:*:*
cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:3.1:*:*:*:*:*:*:*

More vulnerabilities in Smiths-medical Cadd-solis Medication Safety Software

CVE-2016-8358 — High (CVSS 8.5): An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The…

All CVEs affecting Smiths-medical Cadd-solis Medication Safety Software →

Other CWE-306 (Missing Authentication for Critical Function) vulnerabilities

CVE-2026-54309 — Critical (CVSS 10.0): n8n is an open source workflow automation platform. Prior to 2.25.7 and 2.26.2, when @n8n/mcp-browser is run in HTTP…
CVE-2026-50242 — Critical (CVSS 10.0): In JetBrains Hub before 2026.1.13757, 2025.3.148033, 2025.2.148048, 2025.1.148120, 2024.3.148430, 2024.2.148429…
CVE-2026-49257 — Critical (CVSS 10.0): mcp-pinot is a Python-based Model Context Protocol (MCP) server for interacting with Apache Pinot. In versions 3.0.1…
CVE-2026-46846 — Critical (CVSS 10.0): Vulnerability in the Oracle WebCenter Portal product of Oracle Fusion Middleware (component: Security Framework).…
CVE-2026-46803 — Critical (CVSS 10.0): Vulnerability in the Oracle WebCenter Portal product of Oracle Fusion Middleware (component: Security Framework).…
CVE-2026-46800 — Critical (CVSS 10.0): Vulnerability in the Oracle WebCenter Sites product of Oracle Fusion Middleware (component: WebCenter Sites).…

Browse all CWE-306 (Missing Authentication for Critical Function) vulnerabilities →